Medizinische Universität Graz - Research portal
Schippinger Walter |
Presentations at scientific and public conferences
Lukasiak, K; Stranz, B; Thurner, E; Stranzl-Lawatsch, H; Schippinger, W; Langsenlehner, U; Langsenlehner, T
Evaluation of the biological age in PCa patients treated with RT using a geriatric assessment
RADIOTHER ONCOL. 2021; 161: S1189-S1189.
[Poster]
Web of Science
König, E; Pux, C; Schippinger, W; Stoiser, E; Krause, R; Zollner-Schwetz, I
Increasing influenza vaccination rates among health care workers and residents of long-term care facilities for the elderly in Graz, Austria.
WIEN KLIN WOCHENSCHR. 2020; 132(SUPPL 2):79-79.-Österreichische Gesellschaft für Innere Medizin ; Sept 24-26, 2020; Salzburg, Austria.
[Poster]
Web of Science
Lichtenegger, K; Kopanz, J; Libiseller, A; Wiesinger, T; Weidinger, L; Laubreiter, L; Schippinger, W; Truskaller, T; Beck, P; Holl, B; Pieber, T; De Campo, A
DIGITAL DECISION SUPPORT FOR BASAL INSULIN THERAPY: RCT CONFIRMED READINESS FOR IMPLEMENTATION IN ACUTE-GERIATRIC CARE PATIENTS WITH TYPE 2 DIABETES.
DIABETES TECHNOL THE. The Official Journal of ATTD: Advanced Technologies & Treatments for Diabetes Conference. 2020; 22: A110-A111.-Advanced Technologies & Treatments for Diabetes Conference; FEB 19-22, 2020; Madrid, SPAIN.
[Poster]
Web of Science
Donsa, K; Stampfer, P; Truskaller, T; Kopanz, J; Konig, C; Lichtenegger, K; Mrak, P; Pinter, G; Schippinger, W; Sinner, F
Development of an innovative eHealth System for comprehensive Quality Assurance and Therapy Support in Austrian Institutions of Acute Geriatrics and Remobilization - Presentation of a user-centered Development Process
Z GERONTOL GERIATR. 2019; 52: S158-S158.
[Poster]
Web of Science
Kalledat, A; Fuchs, H; Pusterhofer, J; Hasenbichler, L; Schippinger, W; Leithner, A; Sendlhofer, G
Interdisziplinäre Zusammenarbeit in der Altersmedizin am Beispiel des Aufbaus eines Alterstraumazentrums
Kongress Altersmedizin; Oct 10-12, 2019; Graz, AUSTRIA . 2019.
[Poster]
Kopanz, J; Libiseller, A; Lichtenegger, KM; De Campo, A; Wiesinger, T; Weidinger, L; Laubreiter, L; Schippinger, W; Truskaller, T; Augustin, T; Beck, P; Höll, B; Pieber, TR
Efficacy, safety and usability of a basal insulin algorithm incorporated into a tablet-based workflow and decision support system (GlucoTab®) for glycemic management in patients with type 2 diabetes at an acute geriatric hospital
IAGG-ER. 2019; -IAGG-ER (INTERNATIONAL ASSOCIATION OF GERONTOLOGY AND GERIATRICS EUROPEAN REGION CONGRESS); MAY 23-25; Gothenburg, SWEDEN.
[Poster]
Libiseller, A; Kopanz, J; Lichtenegger, KM; De Campo, A; Wiesinger, T; Weidinger, L; Laubreiter, L; Schippinger, W; Truskaller, T; Augustin, T; Beck, P; Höll, B; Pieber, TR
Wirksamkeit, Sicherheit und Benutzerfreundlichkeit eines mobilen elektronischen Arbeitsablauf- und Entscheidungsunterstützungssystems (GlucoTab®) mit integriertem Basalinsulin Algorithmus für das Blutzuckermanagement bei PatientInnen mit Typ-2-Diabetes in der Akutgeriatrie
14. GEMEINSAMER ÖSTERREICHISCH-DEUTSCHER GERIATRIEKONGRESS, 59. KONGRESS DER ÖSTERREICHISCHEN GESELLSCHAFT FÜR GERIATRIE UND GERONTOLOGIE; APR 25-27; Vienna, AUSTRIA. 2019.
[Poster]
FullText
Libiseller, A; Lichtenegger, KM; Kopanz, J; De Campo, A; Wiesinger, T; Weidinger, L; Laubreiter, L; Schippinger, W; Truskaller, T; Lackner, B; Beck, P; Höll, B; Pieber, TR
Verbessertes Blutzuckermanagement bei geriatrischen PatientInnen mit Typ 2 Diabetes Mellitus durch Anwendung eines Basalinsulin Algorithmus
4. Primärversorgungskongress; APR 4-6; Graz, AUSTRIA. 2019.
[Oral Communication]
Libiseller, A; Lichtenegger, KM; Kopanz, J; De Campo, A; Wiesinger, T; Weidinger, L; Laubreiter, L; Schippinger, W; Truskaller, T; Lackner, BC; Beck, P; Holl, B; Pieber, TR
Improving Glycemic Management of Patients with Type 2 Diabetes in Acute Geriatric Care by Using a Basal Insulin Algorithm Incorporated into a Workflow and Decision Support System
DIABETES. Diabetes 2019 Jun; 68(Supplement 1): -. . 2019; 68: -79th Scientific Sessions of the American-Diabetes-Association (ADA); JUN 07-11, 2019; San Francisco, CA.
Doi: 10.2337/db19-952-P
[Poster]
Web of Science
FullText
FullText_MUG
Libiseller, A; Lichtenegger, KM; Kopanz, J; Wiesinger, T; Weidinger, L; Laubreiter, L; Schippinger, W; Truskaller, T; Lackner, B; Beck, P; Höll, B; Pieber, TR; de Campo, A
Wirksames und sicheres Blutzuckermanagement bei geriatrischen PatientInnen mit Typ-2-Diabetes durch Verwendung eines digitalen Basalinsulin-Algorithmus
Netzwerk Altersmedizin Steiermark Jahreskongress; OKT 10-12; Graz, AUSTRIA. 2019.
[Poster]
Gschwandtner, E; Faffelberger, C; Lindenmann, J; Fink-Neubock, N; Fediuk, M; Schippinger, W; Bitsche, S; Porubsky, C; Smolle-Juttner, FM
Quality of Life in palliative patients with lung cancer in a palliative setting
WIEN KLIN WOCHENSCHR. 2017; 129(19-20):775-775.-41. Jahrestagung der Österreichischen Gesellschaft für Pneumologie- 1. Jahrestagung der Österreichischen Gesellschaft für Thoraxchirurgie; OCT 5-7, 2017; Innsbruck, AUSTRIA.
[Poster]
Web of Science
Zollner-Schwetz, I; Zechner, E; Ullrich, E; Pux, C; Pichler, G; Schippinger, W; Krause, R; Leitner, E
Colonization with multidrug-resistant Gram-negative bacteria in long time care facilities: prevalence and risk factors
WIEN KLIN WOCHENSCHR. 2016; 128: S387-S388.
[Poster]
Web of Science
Landsmann, B; Pinter, D; Pirker, E; Wallack, E; Pichler, G; Schippinger, W; Ropele, S; Gattringer, T; Fazekas, F; Enzinger, C
An exploratory intervention study suggests clinical benefits of training in chronic stroke to be paralleled by changes in brain activity using repeated fMRI
EUR J NEUROL. 2015; 22: 407-407.-1st Congress of the European-Academy-of-Neurology; June 20-23, 2015; Berlin, Germany.
[Poster]
Web of Science
Schippinger, W; Stepan, V
Das Geriatrie Board des Zentrums Medizn für alte Menschen in Graz.
Österreichisch-Deutscher Geriatriekongress Wien, ; März 21-23, 2013; Vienna, Austria. 2013.
[Oral Communication]
FullText
Hofmann, G; Bitsche, S; Osprian, I; Verebes, J; Greimel, A; Schippinger, W; Dandachi, N; Samonigg, H; Heitzer, E; EPCRC
Biomarkers as Possible Indicators for Pain Experience ansd Treatment Outcome.
Palliative Medicine. 2012; 26(4):428-429.-7th World Research Congress of the European Association for Palliative Care; JUNE 7-9, 2012; Trondheim, NORWAY.
[Oral Communication]
Marx-Neuhold, EA; Zulus, B; Absenger, G; Szkandera, J; Schippinger, W; Gerger, A; Renner, W
A common polymorphism in the promoter of the erythropoietin gene is associated with delayed onset of peripheral arterial disease.
Drug Metabolism and Drug Interactions. 2012; 27(3):39-39.-6th Santorini Conference Biologie Prospective; SEP 30-OKT 2, 2012; Thira, GREECE.
[Poster]
Szkandera, J; Absenger, G; Stotz, M; Weissmuller, M; Winder, T; Langsenlehner, T; Samonigg, H; Renner, W; Schippinger, W; Gerger, A
The functional polymorphism of erythropoietin gene rs1617640 G > T is not associated with susceptibility and clinical outcome of early-stage breast cancer
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):575-575.
[Poster]
Web of Science
Szkandera, J; Zulus, B; Absenger, G; Stotz, M; Weissmueller, M; Winder, T; Langsenlehner, T; Samonigg, H; Renner, W; Schippinger, W; Gerger, A
The functional rs1617640 polymorphism in the promoter of the erythropoietin gene is not associated with susceptibility and outcome of early-stage breast cancer.
Drug Metabolism and Drug Interactions. 2012; 27(3):22-22.-6th Santorini Conference Biologie Prospective.; SEP 30-OKT 2, 2012; Thira, GREECE.
[Poster]
Eisner, F; Schippinger, W; Samonigg, H
Impact of therapy with octreotide and butylscopolamine on frequency of emesis in malignant chronic bowel obstruction
11th EAPC Congress, Vienna. 2009; -EAPC; MAY 7-10, 2009; Vienna, AUSTRIA.
[Poster]
Gnant, M; Mlineritsch, B; Schippinger, W; Luschin-Ebengreuth, G; Poestlberger, S; Menzel, C; Jakesz, R; Kubista, E; Marth, C; Greil, R
ADDITION OF ZOLEDRONIC ACID (ZOL) TO ADJUVANT ENDOCRINE THERAPY IMPROVES DISEASE-FREE (DFS) AND RECURRENCE-FREE SURVIVAL (RFS) IN PREMENOPAUSAL WOMEN WITH HORMONE-RESPONSIVE EARLY BREAST CANCER (HREBC): MULTIVARIATE ANALYSES OF THE AUSTRIAN BREAST AND COLORECTAL CANCER STUDY GROUP 12 (ABCSG-12) TRIAL
ANN ONCOL. 2009; 20: 30-30.-IMPAKT Breast Cancer Conference; MAY 7-9, 2009; Brussels, BELGIUM.
[Poster]
Web of Science
Gnant, M; Mlineritsch, B; Schippinger, W; Luschin-Ebengreuth, G; Steger, G; Bjelic-Radisic, V; Jakesz, R; Kubista, E; Marth, C; Greil, R
The number needed to treat (NNT) as a measure of drug efficacy: the case of zoledronic acid for early hormone-responsive breast cancer in the ABCSG-12 trial
CANCER RES. 2009; 69(2):191S-191S.-31st Annual San Antonio Breast Cancer Symposium; DEC 10-14, 2008; San Antonio, TX.
[Oral Communication]
Web of Science
Gnant, M; Mlineritsch, B; Schippinger, W; Luschin-Ebengreuth, G; Steger, G; Bjelic-Radisic, V; Jakesz, R; Kubista, E; Marth, C; Greil, R
Number needed to treat (NNT) as a drug efficacy measure: Zoledronic acid (ZOL) for early hormone-responsive breast cancer in the ABCSG-12 trial
BREAST. 2009; 18: S59-S59.
Doi: 10.1016/S0960-9776(09)70187-0
Web of Science
FullText
FullText_MUG
Gnant, M; Mlineritsch, B; Schippinger, W; Luschin-Ebengreuth, G; Steger, GG; Bjelic-Radisic, V; Jakesz, R; Kubista, E; Marth, C; Greil, R
NUMBER NEEDED TO TREAT (NNT) AS A MEASURE OF ZOLEDRONIC ACID (ZOL) EFFICACY IN PATIENTS WITH HORMONE-RESPONSIVE EARLY BREAST CANCER (BC) IN THE AUSTRIAN BREAST AND COLORECTAL CANCER STUDY GROUP (ABCSG)-12 TRIAL
ANN ONCOL. 2009; 20: 30-30.
Web of Science
Osprian, I; Schippinger, W; Samonigg, H;
Prevalence of Anaemia in Cancer Patients Receiving Palliative Care
Abstract book of the 11th Congress of the EAPC
2009; -11th Congress of the European Association for Palliative Care; 7-10 May 2009 ; Vienna, Austria.
[Poster]
Schippinger, W; Osprian, I; Eisner, F; Samonigg, H;
Chronic Renal Insufficiency in Palliative Care: Possible Impact on Drug Excretion.
Abstract book of the 11th Congress of the EAP2009; -11th Congress of the European Association for Palliative Care; 7-10 May 2009 ; Vienna, Austria.
[Poster]
Schippinger, W; Osprian, I; Spat, S; Pilgram, H; Baumgartner, J; Samonigg, H;
Economic effects of palliative care provided by a home care support team of a University hospital in Austria.
Abstract book of the 11th Congress of the EAPC2009; -11th Congress of the European Association for Palliative Care; 7-10 May 2009 ; Vienna, Austria.
[Poster]
Gnant, M; Mlineritsch, B; Schippinger, W; Luschin-Ebengreuth, G; Steger, GG; Bjelic-Radisic, V; Jakesz, R; Kubista, E; Marth, C; Greil, R
ZOLEDRONIC ACID (ZOL) IMPROVES DISEASE-FREE (DFS) AND RECURRENCE-FREE SURVIVAL (RFS) IN PREMENOPAUSAL WOMEN WITH EARLY BREAST CANCER (ERBC) RECEIVING ADJUVANT ENDOCRINE THERAPY: MULTIVARIATE ANALYSIS OF EFFICACY DATA FROM THE AUSTRIAN BREAST AND COLORECTAL CANCER STUDY GROUP (ABCSG)-12
ANN ONCOL. 2008; 19: 44-44.-33rd European-Society-for-Medical-Oncology Congress; SEP 12-16, 2008; Stockholm, SWEDEN.
[Keynote lecture]
Web of Science
Hofmann, G; Dandachi, N; Balic, M; Schippinger, W; Samonigg, H; Regitnig, P; Bauernhofer, T
Soluble E-Cadherin and ist prognostic impact on response to neoadjuvant anthracycline-based chemotherapy in breast cancer patients.
Onkologie2008; 31 (suppl 4): 161-162.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 10-14, 2008; Vienna, AUSTRIA.
[Oral Communication]
Spat, S; Habacher, W; Rakovac, I; Baumgartner, J; Schippinger, W; Samonigg, H; Pieber, TR
SHIFT OF PUBLIC HEALTH CARE EXPENDITURES FOR PALLIATIVE CANCER PATIENTS FROM INPATIENT TO OUTPATIENT EFFECTED BY HOME CARE SUPPORT TEAMS PROVIDED BY A UNIVERSITY HOSPITAL IN AUSTRIA
VALUE HEALTH. 2008; 11(6):A479-A480.
Doi: 10.1016/S1098-3015(10)66600-4
[Oral Communication]
Web of Science
FullText
FullText_MUG
Bauernhofer,T; Schippinger,W; Weitzer,W; Stöger, H; Samonigg,H;
Neoadjuvant therapy with liposomal doxorubicin in combination with docetaxel and trastuzumab in patients with locally advanced her2/neu positive breast cancer
Wiener Medizinische Wochenschrift2007; 157(121):9-9.-Frühjahrestagung 2007
der Österreichischen Gesellschaft für Hämatolgie und Onkologie (ÖGHO)
und der Arbeitsgemeinschaft hämato-onkologischer Pflegepersonen in Österreich (AHOP)
; APR 12-14, 2007; Vienna, Austria.
[Oral Communication]
Gnant, M; Mlineritsch, B; Luschin-Ebengreuth, G; Kainberger, F; Kaessmann, H; Piswanger-Soelkner, C; Seifert, M; Schippinger, W; Menzel, C; Dubsky, P; Fitzal, F; Steger, G; Greil, R; Marth, C; Kubista, E; Samonigg, H; Jakesz, R
Bone mineral density (BMD) at 5 years after diagnosis in premenopausal patients with endocrine-responsive breast cancer, after 3 years of adjuvant endocrine treatment with goserelin and tamoxifen or anastrozole or both treatments in combination with zoledronic acid - new results from ABCSG-12
BREAST CANCER RES TREAT. 2007; 106: S8-S8.
[Oral Communication]
Web of Science
Schippinger, W; Dandachi, N; Regitnig, P; Hofmann, G; Balic, M; Schug, A; Bauernhofer, T; Samonigg, H
Influence of neoadjuvant chemotherapy on the HER-2/neu status of breast cancer tissue.
Supplement 121; 157(25):28-28.-Frühjahrstagung 2007 der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 12-14, 2007; Vienna, AUSTRIA .
[Poster]
Schippinger, W; Holub, R; Dandachi, N; Bauernhofer, T
Frequency of febrile neutropenia in patients treated with taxane/epirubicine and colony-stimulating growth factors for breast cancer: comparison of filgrastim/lenograstim with pegfilgrastim
BREAST CANCER RES. 2007; 9(1):
Doi: 10.1186/bcr1722
[Poster]
Web of Science
FullText
FullText_MUG
Schippinger, W; Lileg, B; Ploner, F; Weitzer, W; Bauemhofer, T; Samonigg, H
Neoadjuvant chemotherapy with non-pegylated liposomal doxorubicin, docetaxel and trastuzumab in HER-2/neu overexpressing breast cancer
ANN ONCOL. 2007; 18: 166-166.
[Poster]
Web of Science
Schippinger,W; Regitnig,P; Dandachi,N; Wernecke,KD; Bauernhofer,T; Samonigg,H;Moinfar, F;
Examination of the prognostic significance of androgen receptor expression in metastatic breast cancer
Wiener Medizinische Wochenschrift2007; 157(121):8-8.-Frühjahrestagung 2007
der Österreichischen Gesellschaft für Hämatolgie und Onkologie (ÖGHO)
und der Arbeitsgemeinschaft hämato-onkologischer Pflegepersonen in Österreich (AHOP)
; APR 12-14, 2007; Vienna, Austria.
[Oral Communication]
Gnant, M; Greil, R; Kubista, E; Menzel, C; Schippinger, W; Seifert, M; Haider, K; Mlineritsch, B; Samonigg, H; Kwasny, W; Fridrik, M; Steger, G; Steindorfer, P; Schmelitsch, J; Poetter, R; Jakesz, R
The impact of treatment-induced amenorrhea on survival of premenopausal patients with endocrine-responsive breast cancer: 10-year results of ABCSG-05 (CMF vs. goserelin plus tamoxifen).
BREAST CANCER RES TREAT. 2006; 100: S10-S11.
[Poster]
Web of Science
Steger, GG; Greil, R; Samonigg, H; Jakesz, R; Bartsch, R; Mlineritsch, B; Melbinger-Zeinitzer, E; Marth, C; Schippinger, W; Gnant, MF
An interim safety analysis of ABCSG-24: 6 cycles of docetaxel, epirubicin, and capecitabine plus pegfilgrastim (DEC) vs. 6 cycles of docetaxel and epirubicin plus pegfilgrastim (DE) in the neoadjuvant treatment of operable breast cancer.
BREAST CANCER RES TREAT. 2006; 100: S156-S156.
[Poster]
Web of Science
Strohscheer, I; Schippinger, W; Samonigg, H
Behandlung einer therapierefraktären Hyperkalzämie bei fortgeschrittenenm Mammakarzinom durch Chemotherapie
-6. Kongress der Deutschen Gesellschaft für Palliativmedizin
; SEP 21-23, 2006; Hamburg.
[Poster]
Hofmann, G; Dandachi, N; Balic, M; Schippinger, W; Resel, M; Wernecke, KD; Samonigg, H; Bauernhofer,T;
Serum levels of soluble E-cadherin as possible predictive and prognostic marker in female breast cancer patients undergoing neoadjuvant therapy.
Wiener Medizinische Wochenschrift2005; 155(117):2-3.-Frühjahrstagung 2005 der Österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO)und der Arbeitsgemeinschaft hämato-onkologischer Pflegepersonen in Österreich
; APR 28-30, 2005; Graz, Austria.
[Oral Communication]
Hofmann, G; Dandachi, N; Balic, M; Schippinger, W; Wernecke, KD; Samonigg, H; Bauernhofer, T
Quantitative measurement of soluble E-cadherin in sera of breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy and its predictive and prognostic value.
J CLIN ONCOL 2005 23: 70S-70S.
Web of Science
Possinger, K; Schippinger, W; Kiewe, P; Lange, W; Preiss, J; Niederle, N; Brossart, P; Papke, J; Freier, W; de Velde, HV; Schmid, P
Phase I trial of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines.
J CLIN ONCOL 2005 23: 66S-66S.
Web of Science
Schippinger,W; Regitnig,P; Moinfar,F; Dandachi,N; Bauernhofer,T; Wernecke,WD; Samonigg,H;
Häufigkeit der Expression von Androgen-Rezeptoren beim Mammakarzinom.
Wiener Medizinische Wochenschrift2005; 155(117):11-11.-Frühjahrstagung 2005 der Österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO) und der Arbeitsgemeinschaft hämato-onkologischer Pflegepersonen in Österreich; APR 28-30, 2005; Graz, Austria.
[Poster]
Schmid, P; Schippinger, V; Kiewe, P; Lange, W; Preiss, J; Niederle, N; Brossart, P; Freier, W; Van de Velde, H; Possinger, K
Bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines.
BREAST CANCER RES TREAT 2005 94: -.
Web of Science
Schmid, P; Schippinger, W; Nitsch, T; Huebner, G; Kreienberg, R; Schultze, W; Hausmaninger, H; Wischnewsky, M; Samonigg, H; Possinger, K
Up-front tandem high-dose chemotherapy (HD) compared to standard chemotherapy with doxorubicin and paclitaxel (AT) in metastatic breast cancer (MBC): Final results of a randomized trial.
J CLIN ONCOL 2004 22: 37S-37S.
Web of Science
Schippinger, W; Bauernhofer, T; Regitnig, P; Ploner, F; Krippl, P; Hofmann, G; Lax, S; Carney, W; Neumann, R; Wernecke, KD; Samonigg, H
Serum HER-2/neu dynamics in metastatic breast cancer as an independent prognostic factor.
BREAST CANCER RES TREAT 2003 82: S123-S123.
Web of Science
Schmid, P; Schippinger, W; Nitsch, T; Huenbner, G; Kreienberg, R; Schultze, W; Hausmaninger, H; Wischnewsky, MB; Luftner, D; Samonigg, H; Possinger, K
Up front tandem high-dose chemotherapy compared to standard chemotherapy with doxorubicin and paclitaxel in metastatic breast cancer: updated results of a randomized trial
BREAST CANCER RES TREAT 2003 82: S152-S152.
Web of Science
Kronberger, L; Wagner, P; Puchinger, M; Stranzl, H; Lax, SF; Kohek, P; Linck, FG; Schippinger, W; Thalhammer, M; Rigler, M; Hoess, G; Samonigg, H; Mischinger, HJ; Kapp, K; Rehak, P; Smola, M
Radiofrequency Hyperthermia in Combination with Chemo- and Radiotherapy in Palliative Treatment of Breast Cancer - A Case Report.
Proceedings of the 2nd Cancer Symposium, 25° Congresso Nazionale Società Italiana di Chirurgia Oncologica SICO - 2nd World Congress of WFSOS; Monduzzi Editore, Bologna, ITALY2002; -2nd Cancer Symposium, 25° Congresso Nazionale Società Italiana di Chirurgia Oncologica SICO - 2nd World Congress of WFSOS; Sept 19-21, 2001; Neapel, ITALIEN. (ISBN: 88-323-1920-9 )
[Oral Communication]
Ploner, F; Genser, B; Schippinger, W; Hofmann, G; Samonigg, H
The influence of prognostic factors seems to be constant throughout the course of metastatic breast cancer regardless of therapeutical intervention.
BREAST CANCER RES TREAT. 2002; 76: S48-S48.
Web of Science
Schippinger, W; Bauernhofer, T; Ploner, F; Hofmann, G; Krippl, P; Neumann, R; Wernecke, KD; Samonigg, H
Serum HER-2/neu levels correlate with time to progression in therapy of metastatic breast cancer.
BREAST CANCER RES TREAT 2002 76: S104-S104.
Web of Science
Kronberger, L; Wagner, P; Puchinger, M; Stranzl, H; Linck, G; Schippinger, W; Thalhammer, M; Rigler, M; Hoess, G; Samonigg, H; Mischinger, HJ; Kapp, K; Rehak, P; Smola, M; Kohek, P
Foudroyanter Verlauf eines Frührezidivs nach Mammakarzinom - Ein Fallbericht und Stellung der Hyperthermie in Kombination mit Chemo- (PCT) und Strahlentherapie.
Eur Surg2001; 33(175):366-106.-42. Tagung der Österreichischen Gesellschaft für Chirurgie; JUN 14-16, 2001; Graz, Austria.
[Oral Communication]
Schmid, M; Bauernhofer, T; Resel, M; Ploner, F; Schippinger, W; Gilli, R; Lanzer, G; Truschnig-Wilders, M; Samonigg, H
High-dose chemotherapy with peripheral blood stem cell support for high risk breast cancer.
BONE MARROW TRANSPLANT 1999 23: S42-S42.
Web of Science